is meso always a death sentence or are there people actually beating this

I'm in a similar headspace right now, just like six months into this with my mom. The thing that helped me stop spiraling was talking to her oncologist at Banner in Phoenix about what "Stage III" actually means for her specifically, not just the general statistics. Because yeah, the median survival stuff is real but it's also pulling in people who didn't get aggressive treatment or had other complications, and that wasn't going to be her situation.

Your husband being Stage II is honestly different than what I'm dealing with. From what I've learned, peritoneal actually has some better outcomes than pleural when you catch it early and he can do the heated chemo and surgery combo. I've met people through support groups who've had peritoneal diagnosed in 2019 and they're still here doing regular scans.

The five year survival number you found... that tracks. I asked about this specifically because I needed to know if I was being lied to and the doctor was like, no, people do make it past two years, past five years, it just depends on the person and the treatment plan and honestly some luck too. It's not false hope if your husband is young enough and fit enough for multimodal treatment. That changes the whole game.

CA-125 tracking is smart but also don't let those numbers become your whole life, if that makes sense. My mom was obsessing over hers every week and it was just making her anxious. Now we check them but we're not like refreshing lab results every other day.

How's your husband doing physically right now? That matters more than I thought it would.

So I've been doing exactly what you're doing, like obsessively tracking numbers and reading studies at 11pm when I should be sleeping. My mom's oncologist told me something that actually stuck with me though. She said the median survival gets skewed down because it includes people who get diagnosed very late or can't handle aggressive treatment, but if you catch it early enough and your person can do surgery plus chemo, you're not in that median group anymore. You're in a different population.

My mom is Stage III and honestly some days I'm convinced we're doomed and other days I see her energy pick up after her scans come back stable and I think okay maybe we actually have time here. The people posting from 2019 or 2020? They're real. They're not statistical unicorns. But I don't know what the exact thing is that separates them from worse outcomes. Like is it the surgery they got, or the specific chemo regimen, or their age, or just dumb luck? I can't figure that out no matter how many PDFs I read.

What I will say is your husband being Stage II is genuinely different than Stage III. That matters. And if his oncology team is recommending aggressive treatment and he can tolerate it, that's not false hope you're building on. That's just... the actual plan that works better for some people.

Have they talked about clinical trials with you guys? That's something I wish I'd asked about earlier.

yeah those guys posting from 2019 or 2020 are real and that's what keeps me going some days, honestly. but also like, my mom's team said early detection and being young enough to handle aggressive treatment makes a huge difference, so it's not just luck.

You're asking the right questions and honestly, the fact that you're tracking his CA-125 and reviewing pathology tells me you're already doing better than most people in this situation.

Stage II peritoneal is genuinely different than stage IV pleural like my dad has. The peritoneal cases I've seen through work tend to have better prognosis partly because surgery can be more definitive - cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) actually removes tumor burden in a way that's harder to do with pleural disease. My dad's lungs were already pretty involved by diagnosis so that wasn't really on the table for him.

That 35% five-year survival statistic is real. It's not false hope, it's just... it depends on so many variables that the median gets dragged down. Your husband's age, performance status, whether he's a good surgical candidate, which histology type he has, how he tolerates treatment. I watched my dad go through aggressive chemo starting in March and he had maybe 6 good months where he felt functional. Now we're palliative and that's been the right call since October but he's still here. That's not beating it but it's also not the 12-18 month death sentence people fear.

The people you're seeing from 2019 and 2020 who are still posting? They're not outliers in the sense of being flukes. They're people who likely caught it earlier, got multimodal treatment at a center that does a lot of meso cases, and had bodies that could handle it. That's a real subset. Whether your husband falls into that subset depends on factors you'll know more about once he's had full staging and his oncology team weighs in.

One thing nobody tells you: the statistics are already several years old by publication. Treatment protocols have evolved. Immunotherapy options have expanded since a lot of those survival studies were done.

What's his histology type if you don't mind sharing?

my brother got diagnosed stage 2 pleural back in 2022 so im kinda in the thick of this like you are. hes still here and doing alright which is way better than what the doctors said at first. they gave him the whole "12 to 18 months" talk and i remember thinking thats not a lot of time but then he started chemo and surgery and honestly things changed.

the thing nobody really explains well is that those grim numbers include people who dont get treated or cant get treated, and people who go to regular hospitals instead of places that actually know what theyre doing with meso. my brother went to this specialist center in nashville about 2 hours from here and the difference was huge. the surgeon there had done like hundreds of these cases and that matters more than people realize.

your husband being stage 2 is way different than stage 4. stage 2 means theres still options. my brother did the chemo first then surgery about 8 months after diagnosis and hes been on maintenance stuff since. hes tired alot and some days are rough but hes working part time and doing normal stuff. CA-125 tracking is smart, we did that too and his oncologist said it gives you real data instead of just guessing.

those people posting from 2019 or 2020 that are still around, theyre not outliers exactly. theyre people who caught it stage 1 or 2, got aggressive treatment at places that specialize in meso, and their bodies tolerated the chemo okay. thats not false hope thats just how it actually works for some people. the statistics are real but they dont tell you which category youre gonna land in and honestly nobody knows yet.

You're asking the right questions and honestly, the fact that you're tracking his CA-125 and have his pathology report tells me you're approaching this the way I do with my dad. Stage II peritoneal is actually one of the better prognostic presentations, especially if he's a candidate for cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). That combination genuinely changes outcomes.

The 35% five-year survival number you found is real, and it's not just outliers. Those are people who got aggressive multimodal treatment early. The median survival quoted everywhere (12-18 months) is heavily skewed by patients diagnosed at advanced stages or who can't tolerate treatment. When you stratify by stage and treatment type, the picture shifts. Stage II with complete cytoreduction and HIPEC eligibility? We're talking different ballpark.

My dad was Stage IV pleural when diagnosed in March, so I won't pretend his trajectory is the same as your husband's. But I've spent enough time in oncology and in these forums to see the pattern. The people posting in 2025 from 2019 diagnoses are NOT just lucky genetic lottery winners. They got treatment at a center that does high-volume meso cases (and this matters more than people realize), they tolerated chemo well enough to complete it, and a lot of them caught it earlier. Your husband's Stage II is a huge advantage.

What actually correlates with longer survival based on what I've seen: complete cytoreduction (not partial, complete), ability to finish chemotherapy without dose reductions, lower CA-125 at baseline, and honestly, being treated at a specialized center versus a general oncology practice. That last one might sound harsh but the difference in five-year outcomes between high-volume and low-volume centers is substantial.

Track those CA-125 numbers. Post-treatment markers matter for monitoring. And if he hasn't had a second opinion at a mesothelioma-specific center, I'd push for that now, not later. We did that for my dad at MD Anderson in October and even though his stage was different, it reframed everything about palliative options.

False hope is real and I get why you're worried about it. But informed optimism based on his actual stage and treatment access isn't the same thing.

I'm in a similar spot, just diagnosed Stage II peritoneal in November like your husband. So I get why you're digging into the numbers because yeah, the standard survival stats are terrifying but then you see people here who are 5+ years out and it doesn't add up at first.

The 2023 study you found is real and it's actually more optimistic than a lot of older data. That 35% five-year survival goes up significantly if you're Stage II at diagnosis, if you can tolerate aggressive treatment, and if you get to a center that does a lot of these cases. The Johns-Manville plant I worked at from 1978 to 1985 exposed a bunch of people and I've been tracking what happened to some of them through old coworkers. The ones who got to specialized centers and did HIPEC plus chemotherapy lived longer than the ones who didn't.

It's not false hope and it's not statistical outliers exactly. It's more like there's a real difference between median survival and actual outcomes. The median is dragged down by people diagnosed at Stage III or IV, people who are too sick for surgery, people who get diagnosed at community hospitals instead of mesothelioma centers. Your husband being Stage II and presumably fit enough to consider surgery puts him in a different category than the "12-18 months" crowd.

I've been keeping a spreadsheet of my own labs since diagnosis. The CA-125 tracking is smart. Histology type matters too. Did his report say epithelioid or mixed? Epithelioid tends to respond better to treatment.

What center is he looking at for HIPEC? That's honestly where the real survival differences happen.